Search clinical trials for: Betamethasone-Calcipotriene Topical

Total 5880 results

Northwestern University

Terminated

Molecular Effects of Topical Calcipotriene on Morphea

Morphea | Localized Scleroderma

United States
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

Scalp Psoriasis

United States
Massachusetts General Hospital

Terminated

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Breast Cancer

United States
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

Psoriasis Vulgaris

United States
LEO Pharma

Completed

PSOREAL - Managing PSOriasis in the REAL World (PSOREAL)

Psoriasis Vulgaris

United Kingdom, Canada, Sweden
Centre Hospitalier Universitaire de Nice

Completed

Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin (Microbiome&Pso)

Psoriasis Vulgaris

France
LEO Pharma

Completed

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)

Psoriasis Vulgaris

United States
Wake Forest University
LEO Pharma

Completed

Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris (PSTaclonex)

Plaque Psoriasis

United States
Odense University Hospital

Completed

Adherence in Topical Treatment of Psoriasis

Adherence

Denmark
Derm Research, PLLC

Completed

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

Plaque Psoriasis

United States
Angeles Florez

Completed

Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life (ENUPS)

Nail Psoriasis

Spain
Skin Sciences, PLLC

Unknown

Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis

Plaque Psoriasis

United States
LEO Pharma

Completed

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

Psoriasis Vulgaris

United States
Derm Research, PLLC
Genentech, Inc.

Terminated

Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)

Plaque Psoriasis

United States
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis

Scalp Psoriasis

United States
Tolmar Inc.

Completed

BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis

Scalp Psoriasis

United States
L.H. Kircik, M.D.

Completed

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

Plaque Psoriasis

United States
LEO Pharma

Completed

Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis

Psoriasis

United States
Prism Pharma Co., Ltd.

Completed

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

Psoriasis

Germany
University of Alabama at Birmingham

Completed

A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis

Nail Psoriasis

United States
Assiut University

Completed

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis

Psoriasis Vulgaris | Fractional CO2 Laser

Egypt
Bayer

Completed

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Psoriasis

Germany
Incyte Corporation

Completed

A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

Psoriasis

United States
LEO Pharma

Completed

Body PSOriasis: Long-term Relapse CONTROL (PSO-CONTROL)

Psoriasis Vulgaris

Russian Federation
LEO Pharma

Completed

LEO19123 Cream in the Treatment of Atopic Dermatitis

Atopic Dermatitis

United Kingdom, Finland, Canada, Denmark
DFB Soria, LLC
Bioskin GmbH; US Biotest, Inc.

Completed

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

Plaque Psoriasis

United States
GlaxoSmithKline

Completed

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

Psoriasis

France
Galderma R&D

Completed

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Plaque Psoriasis

United States
Massachusetts General Hospital
Washington University School of Medicine

Not yet recruiting

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Skin Cancer | Actinic Keratoses | Immunotherapy | Cutaneous Squamous Cell Carcinoma | Organ Transplant Recipients

United States
Cairo University

Completed

Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.

Atopic Dermatitis

Egypt
Postgraduate Institute of Medical Education and...

Unknown

Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis

Psoriasis
Bayer

Completed

1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

Psoriasis

Germany
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Psoriasis of Scalp

Canada, Denmark, France, Norway, Portugal, Spain, Sweden, United Kingdom
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris

Psoriasis Vulgaris

Ireland, Germany, United Kingdom, Canada, Sweden
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

China
LEO Pharma

Completed

Efficacy and Tolerability of Enstilar® in Daily Practice

Plaque Psoriasis

Germany
Psoriasis Treatment Center of Central New Jersey

Completed

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Psoriasis

United States
Carilion Clinic

Recruiting

Combination 5-FU / Calcipotriene Cream for SCCIS/SCC

Squamous Cell Carcinoma

United States
Jooheung Lee

Completed

Study for Treatment With Calcipotriol/Betamethasone Dipropionate Gel in Korean Patients With Psoriasis Vulgaris (TRIANGLE)

Psoriasis Vulgaris

Korea, Republic of
Assiut University

Not yet recruiting

Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.

Alopecia Areata

Egypt
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis

Psoriasis of Scalp

Canada, Belgium, Finland, France, Germany, Netherlands, United Kingdom
Cairo University

Not yet recruiting

Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease

Oral Ulceration Due to Behçet's Disease
Pfizer

Completed

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Psoriasis

Germany
LEO Pharma

Completed

Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis

Psoriasis of Scalp

France, Canada, Belgium, Denmark, Sweden
Derm Research, PLLC

Unknown

The Maintenance Effect of Enstilar Foam in Combination With Otezla

Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis

Psoriasis

United States
Lipidor AB

Recruiting

A Phase III Study in Subjects With Mild to Moderate Psoriasis. (AKVANO-AKP02)

Mild to Moderate Psoriasis

India
LEO Pharma

Completed

Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study (BODYGUARD)

Psoriasis Vulgaris

Russian Federation
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

Psoriasis of Scalp

Canada, Denmark, France, Germany, United Kingdom
Mayne Pharma International Pty Ltd
GlaxoSmithKline

Completed

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Psoriasis

United States

3

Subscribe